Saturday, 21 November 2026
FDA Approves New Bladder Cancer Treatment Before Surgery
Study Abstracts

FDA Approves New Bladder Cancer Treatment Before Surgery

The FDA has approved a new bladder cancer treatment combining durvalumab and enfortumab vedotin, reducing recurrence risk by 49%.

By Cika Rahardjo  •  16/11/2026
AI and treatment gaps worsen CLL care disparities
Research Briefs

AI and treatment gaps worsen CLL care disparities

AI and treatment gaps worsen disparities in CLL care, leaving minority and rural patients less likely to receive guideline-recommended therapies…

By Cika Rahardjo  •  14/11/2026
Insurance rules limit access to new COPD biologics
Research Briefs

Insurance rules limit access to new COPD biologics

Insurance policies now restrict access to new COPD biologics, limiting treatment options for patients with eosinophilic COPD despite medical guidelines.

By Cika Rahardjo  •  12/11/2026
Oral therapy may expand myeloma treatment access
Journal Drops

Oral therapy may expand myeloma treatment access

Oral therapy may expand access to myeloma treatment options for patients worldwide, according to Dr. Mateo Mejia Saldarriaga.

By Cika Rahardjo  •  09/11/2026
New IL-17 inhibitors outperform others for scalp psoriasis treatment
Journal Drops

New IL-17 inhibitors outperform others for scalp psoriasis treatment

New research shows IL-17 inhibitors like ixekizumab and brodalumab may offer one of the most effective short-term treatments for scalp…

By Rara Setiawati  •  07/11/2026
Tomato Compound Holds Fatty Liver Hope
Study Abstracts

Tomato Compound Holds Fatty Liver Hope

Tomato compound phytoene shows promise in fighting fatty liver disease, benefiting the estimated 100 million Americans affected. Discover the findings.

By Yulia Puspitasari  •  28/08/2026